The epidemiology of glioma in adults: a "state of the science" review

Эпидемиология глиом у взрослых: обзор «современного состояния научных знаний»
Jill S. Barnholtz‐Sloan, Faith G. Davis, James L. Fisher, Luc Bauchet, Quinn T. Ostrom, Melike Pekmezci, Michelle C. Turner, Margaret Wrensch, Kyle M. Walsh, Isabelle Deltour, Chelsea Eastman Langer, Judith Schwartzbaum
2014-05-19

adult glioma epidemiologygenome-wide association studiesglioblastomaglioma biomarkersionizing radiation
Gliomas are the most common primary intracranial tumor, representing 81% of malignant brain tumors. Although relatively rare, they cause significant mortality and morbidity. Glioblastoma, the most common glioma histology (∼45% of all gliomas), has a 5-year relative survival of ∼5%. A small portion of these tumors are caused by Mendelian disorders, including neurofibromatosis, tuberous sclerosis, and Li-Fraumeni syndrome. Genomic analyses of glioma have also produced new evidence about risk and prognosis. Recently discovered biomarkers that indicate improved survival include O⁶-methylguanine-DNA methyltransferase methylation, isocitrate dehydrogenase mutation, and a glioma cytosine-phosphate-guanine island methylator phenotype. Genome-wide association studies have identified heritable risk alleles within 7 genes that are associated with increased risk of glioma. Many risk factors have been examined as potential contributors to glioma risk. Most significantly, these include an increase in risk by exposure to ionizing radiation and a decrease in risk by history of allergies or atopic disease(s). The potential influence of occupational exposures and cellular phones has also been examined, with inconclusive results. We provide a “state of the science” review of current research into causes and risk factors for gliomas in adults.
1
A small proportion of adult gliomas arise from Mendelian disorders, including neurofibromatosis, tuberous sclerosis, and Li-Fraumeni syndrome.
2
Evidence linking occupational exposures and cellular-phone use to glioma risk remains inconclusive.
3
Genome-wide association studies identified heritable risk alleles in seven genes associated with increased glioma risk; ionizing radiation increases risk, whereas allergies or atopic disease decrease risk.
4
Glioblastoma represents approximately 45% of gliomas and has an approximately 5% five-year relative survival rate.
5
Gliomas constitute 81% of malignant brain tumors and cause substantial mortality and morbidity despite being relatively rare.
6
MGMT methylation, IDH mutation, and the glioma-CpG island methylator phenotype are biomarkers associated with improved survival.

Adult gliomas

Their epidemiology, including causes, risk factors, heritable susceptibility, genomic prognostic biomarkers, and survival-related features

Publication Details
Publication Date
2014-05-19
Journal
Publisher
ISSN
Cited by
2345
Access Type
Author Information
Authors
Jill S. Barnholtz‐Sloan
Faith G. Davis
James L. Fisher
Luc Bauchet
Quinn T. Ostrom
Melike Pekmezci
Michelle C. Turner
Margaret Wrensch
Kyle M. Walsh
Isabelle Deltour
Chelsea Eastman Langer
Judith Schwartzbaum
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%